Shri Shyam Prime Commodities Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 130.54%
(FY 2020)
- Profit 68.43%
(FY 2020)
- Ebitda 87.70%
(FY 2020)
- Net Worth -16.75%
(FY 2020)
- Total Assets -9.40%
(FY 2020)
About Shri Shyam Prime Commodities
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Khandelwal, Sourabh Khandelwal, and Keshav Khandelwal serve as directors at the Company.
- CIN/LLPIN
U52190RJ2012PTC038401
- Company No.
038401
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationAjmer, Rajasthan
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Shri Shyam Prime Commodities Private Limited offer?
Shri Shyam Prime Commodities Private Limited offers a wide range of products and services, including Homeopathic Drugs, Sugar Globules.
Who are the key members and board of directors at Shri Shyam Prime Commodities?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Khandelwal  | Director | 29-Mar-2012 | Current |
| Sourabh Khandelwal | Director | 29-Mar-2012 | Current |
| Keshav Khandelwal | Director | 29-Mar-2012 | Current |
Financial Performance of Shri Shyam Prime Commodities.
Shri Shyam Prime Commodities Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 130.54% increase. The company also saw a substantial improvement in profitability, with a 68.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Shyam Prime Commodities?
In 2020, Shri Shyam Prime Commodities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Safpure Lifesciences Private LimitedActive 11 years 8 monthsGaurav Khandelwal and Sourabh Khandelwal are mutual person
- Rasik Remedies Private LimitedActive 15 years 5 months
Gaurav Khandelwal, Sourabh Khandelwal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shri Shyam Prime Commodities?
Unlock and access historical data on people associated with Shri Shyam Prime Commodities, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Shyam Prime Commodities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Shyam Prime Commodities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
